+181.9%
FANG vs THC
+1,022.1%
-840.2%
-88.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | +0.1% | -0.3% | -0.2% |
| 7D | +2.9% | -0.5% | +3.4% | +3.0% |
| 30D | +2.6% | -1.2% | +3.8% | +2.9% |
| 3M | +7.6% | +52.3% | -44.7% | -6.0% |
| 6M | +17.3% | +12.4% | +4.9% | +10.9% |
| YTD | +38.7% | +32.7% | +6.0% | +23.9% |
| 1Y | +51.6% | +36.4% | +15.3% | +33.5% |
| 3Y | +50.0% | +259.3% | -209.3% | -7.6% |
| 5Y | +237.6% | +262.7% | -25.1% | +91.7% |
| All | +181.9% | +1,022.1% | -840.2% | +12.1% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling